#
Imogam Rabies-HT
  • Treatments
  • Rabies Prophylaxis
  • Imogam Rabies-HT (Intramuscular)

Imogam Rabies-HT (Intramuscular)

Generic name:rabies immune globulin (intramuscular route) [ RAY-beez-i-MUNE-GLOB-ue-lin ]
Drug class:Immune globulins

Medically reviewed by Drugs.com. Last updated on Mar 18, 2022.

Commonly used brand name(s)

In the U.S.

  • Bayrab
  • HyperRAB S/D
  • Imogam Rabies-HT
  • Kedrab

Available Dosage Forms:

  • Solution

Therapeutic Class: Immune Serum

Uses for Imogam Rabies-HT

Rabies immune globulin is used together with rabies vaccine to prevent infection caused by the rabies virus. It works by giving your body the antibodies it needs to protect it against the rabies virus. This is called passive protection. This passive protection lasts long enough to protect your body until it can produce its own antibodies against the rabies virus.

Rabies immune globulin is given to persons who have been exposed (eg, by a bite, scratch, or lick) to an animal that is known or thought to have rabies. This is called post-exposure prophylaxis. Rabies immune globulin is used only in persons who have never before received the rabies vaccine.

Rabies infection is serious and often fatal. In the U.S., rabies in wild animals, especially raccoons, skunks, and bats, accounts for the most cases of rabies passed on to humans, pets, and other domestic animals. In Canada, the animals most often infected with rabies are foxes, skunks, bats, dogs, and cats. Horses, swine, and cattle have also been known to become infected with rabies. In much of the rest of the world, including Latin America, Africa, and Asia, dogs account for the most cases of rabies passed on to humans.

If you are being (or will be) treated for a possible rabies infection while traveling outside of the U.S. or Canada, contact your doctor as soon as you return to the U.S. or Canada, since it may be necessary for you to have additional treatment.

This medicine is to be given only by or under the supervision of your doctor or other health care professional.

Before using Imogam Rabies-HT

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of rabies immune globulin in the pediatric population. Safety and efficacy have not been established.

Geriatric

No information is available on the relationship of age to the effects of HyperRAB® in geriatric patients.

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of KedRAB® in the elderly.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during brea...